Medtech firm gets new start in Austin
Acessa Health acquired noninvasive treatment for uterine fibroids.
It’s been a whirlwind few months for medical device maker Acessa Health.
In June, the company announced it had acquired a noninvasive treatment for uterine fibroids from a California medical device company.
At the same time, the company said it had secured $30 million in Series A financing to expand its product portfolio, develop new technology, and expand sales and marketing.
Meanwhile, Acessa moved from Northern California to Austin, which now serves as its global headquarters.
“Austin is the right place for us,” said Kim Bridges Rodriguez, CEO of Acessa Health. “A lot of small medtech companies are starting to emerge, and I believe this is one of the next big medtech opportunity spots. You have it in Northern California, in Minnesota; it’s starting to emerge in Colorado. I believe Austin will be on that list.”
Acessa (pronounced uh-SESS-a) purchased the FDA-approved device from Halt Medical, a Brent-
Rodriguez: “Austin is the right place for us.”